Catalyst Pharmaceuticals, Inc. (CPRX) Stock Forecast
Data as of May 2, 2026Healthcare · Current price $28.77 (+2.28%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Nov 7, 2025 | Leland Gershell | Oppenheimer | $33.00 | +14.7% |
| Feb 4, 2025 | Joel Beatty | Robert W. Baird | $28.00 | -2.7% |
| Jan 10, 2025 | Andrew Fein | H.C. Wainwright | $35.00 | +21.7% |
| Dec 19, 2022 | Joseph Catanzaro | Piper Sandler | $20.00 | -30.5% |
| Aug 24, 2022 | Scott Henry | Roth Capital | $15.50 | -46.1% |
Top Analysts Covering CPRX
CPRX vs Sector & Market
| Metric | CPRX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 2 | 8 | 18 |
| Target Upside | +14.7% | +1150.3% | +14.9% |
| P/E Ratio | 17.12 | 6.85 | 31.19 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $148M | $152M | $155M | 5 |
| 2026-09-30 | $154M | $159M | $164M | 2 |
| 2026-12-31 | $167M | $173M | $178M | 2 |
| 2027-03-31 | $154M | $160M | $164M | 2 |
| 2027-06-30 | $162M | $168M | $173M | 2 |
| 2027-09-30 | $170M | $176M | $181M | 2 |
| 2027-12-31 | $178M | $184M | $190M | 2 |
| 2028-12-31 | $766M | $766M | $766M | 4 |
| 2029-12-31 | $812M | $844M | $862M | 3 |
| 2030-12-31 | $861M | $894M | $914M | 3 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-06-30 | $0.41 | $0.44 | $0.47 | 3 |
| 2026-09-30 | $0.44 | $0.46 | $0.48 | 1 |
| 2026-12-31 | $0.50 | $0.52 | $0.54 | 1 |
| 2027-03-31 | $0.45 | $0.47 | $0.49 | 1 |
| 2027-06-30 | $0.48 | $0.50 | $0.52 | 1 |
| 2027-09-30 | $0.53 | $0.55 | $0.57 | 1 |
| 2027-12-31 | $0.52 | $0.54 | $0.56 | 1 |
| 2028-12-31 | $1.89 | $2.23 | $2.58 | 2 |
| 2029-12-31 | $2.38 | $2.50 | $2.57 | 1 |
| 2030-12-31 | $2.57 | $2.70 | $2.78 | 1 |
Frequently Asked Questions
What is the analyst consensus for CPRX?
The consensus among 2 analysts covering Catalyst Pharmaceuticals, Inc. (CPRX) is Buy with an average price target of $33.00.
What is the highest price target for CPRX?
The highest price target for CPRX is $35.00, set by Andrew Fein at H.C. Wainwright on 2025-01-10.
What is the lowest price target for CPRX?
The lowest price target for CPRX is $15.50, set by Scott Henry at Roth Capital on 2022-08-24.
How many analysts cover CPRX?
2 analysts have issued ratings for Catalyst Pharmaceuticals, Inc. in the past 12 months.
Is CPRX a buy or sell right now?
Based on 2 analyst ratings, CPRX has a consensus rating of Buy (2.00/5) with a +14.7% upside to the consensus target of $33.00.
What are the earnings estimates for CPRX?
Analysts estimate CPRX will report EPS of $0.44 for the period ending 2026-06-30, with revenue estimated at $152M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.